Datopotamab deruxtecan in solid tumors: Recent research progress and clinical applications - Top-Institutions - MDSpire

Datopotamab deruxtecan in solid tumors: Recent research progress and clinical applications

  • By

  • Ying Cao

  • Li-qin Mo

  • Ya-juan Liu

  • Zhen Zhang

  • July 7, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #4

    Susan F. Smith Center for Women’s Cancers
    Susan F. Smith Center for Women’s Cancers

    Boston, MA

    Key Differentiators

    • Oncology

  • #5

    University of California San Francisco
    University of California San Francisco

    San Francisco, CA

    Key Differentiators

    • Oncology

Original Source(s)

Datopotamab deruxtecan in solid tumors: Recent research progress and clinical applications

  • by Ying Cao, Li-qin Mo, Ya-juan Liu, Zhen Zhang

  • July 7, 2026

Related Content

Isoflavones impair anti-PD1 efficacy in breast cancer, regardless of dietary fiber or fecal short-chain fatty acid levels

Study on the application of thermo-optical surface monitoring + X-ray guidance system in DIBH for breast cancer

Single-port robotic segmentectomy using the da Vinci SP system for non-small cell lung cancer